MENU

Intra-Cellular Therapies (ITCI) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

ITCI is expected to report earnings to rise 16.00% to -18 cents per share on August 06

Intra-Cellular Therapies ITCI Stock Earnings Reports
Q2'24
Est.
$-0.19
Q1'24
Beat
by $0.16
Q4'23
Beat
by $0.15
Q3'23
Beat
by $0.31
Q2'23
Beat
by $0.14
The last earnings report on May 07 showed earnings per share of -15 cents, beating the estimate of -31 cents. With 44.80K shares outstanding, the current market capitalization sits at 6.70B.
View a ticker or compare two or three
ITCI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
430 East 29th Street
Phone
+1 646 440-9333
Employees
610
Web
https://www.intracellulartherapies.com